SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-007204
Filing Date
2019-03-11
Accepted
2019-03-11 17:03:19
Documents
4
Period of Report
2019-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20190311.htm 8-K 35206
2 EX-5.1 abio-ex51_7.htm EX-5.1 15308
3 EX-10.1 abio-ex101_6.htm EX-10.1 23621
4 GRAPHIC gn5sxmf1d1bf000001.jpg GRAPHIC 28720
  Complete submission text file 0001564590-19-007204.txt   115161
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 19672983
SIC: 2835 In Vitro & In Vivo Diagnostic Substances